Most recent Publications:

1.     Jakobsson J, Vincendeau M. SnapShot: Human endogenous retroviruses. Cell. 2022 Jan 20;185(2):400-400.e1. doi: 10.1016/j.cell.2021.12.028.

2.     Liu H, Bergant V, Frishman G, Ruepp A, Pichlmair A, Vincendeau M*, Frishman D*. Influenza A Virus Infection Reactivates Human Endogenous Retroviruses Associated with Modulation of Antiviral Immunity. Viruses. 2022 Jul 21;14(7):1591. doi: 10.3390/v14071591.

3.     Nair VP, Mayer J, Vincendeau M. A protocol for CRISPR-mediated activation and repression of human endogenous retroviruses in human pluripotent stem cells. STAR Protoc. 2022 Apr 12;3(2):101281. doi: 10.1016/j.xpro.2022.101281. eCollection 2022 Jun 17.

4.     Padmanabhan Nair V, Liu H, Ciceri G, Jungverdorben J, Frishman G, Tchieu J, Cederquist GY, Rothenaigner I, Schorpp K, Klepper L, Walsh RM, Kim TW, Cornacchia D, Mayer J, Hadian K, Frishman D, Studer L, Vincendeau M.Activation of HERV-K(HML-2) disrupts cortical patterning and neuronal differentiation by increasing NTRK3. Cell Stem Cell. 2021 Sep 2;28(9):1566-1581.e8. doi: 10.1016/j.stem.2021.04.009. Epub 2021 May 4.

5.     Weber M, Padmanabhan Nair V, Bauer T, Sprinzl MF, Protzer U, Vincendeau M. Increased HERV-K(HML-2) Transcript Levels Correlate with Clinical Parameters of Liver Damage in Hepatitis C Patients. Cells. 2021 Mar 31;10(4):774. doi: 10.3390/cells10040774.